Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
of Computer Science. The research focus of our group is on parallel computing, supercomputing, and performance tuning and optimization of advanced applications. Our team currently consists of 10 scientific and 3
-
We are looking for highly motivated early-career postdoctoral scientists willing to conduct independent research in computational biology at Nantes University in France. Nantes University has
-
into hours, scale evidence review across thousands of studies, and explore many hypotheses in parallel so researchers and clinicians can focus on strategic decisions and patient care. Every solution you build
-
is a highly collaborative, creative, and fun group of scientists at St. Jude Children's Research Hospital. Our research program centers on the development of state-of-the-art genomic methods
-
computing frameworks (e.g., MPI, NCCL) and model parallelism techniques. Proficiency in C++/CUDA programming for GPU acceleration. Experience in optimizing deep learning models for inference (e.g., using
-
architectures, distributed computing, high performance and parallel computing, ethical and sustainable computing, artificial intelligence. The journal will also explore opportunities in emerging and
-
round of its international recruitment campaign to appoint the Founding Heads of its Research Development Labs. Two parallel calls are open: GENERAL CALL https://ai4i.it
-
scholarship amounts to 720 000 SEK in total (360 000 SEK annual average) and is usually paid out as four separate payments during scholarship period. This project is running in parallel with another larger
-
. • Knowledge of parallel computing and use of GPUs are desirable. • Supervision and teaching experience is an advantage. • Expertise in dynamical modelling and stellar spectroscopy are assets. • Presentation
-
protein expression and purification, capable of producing thousands of proteins in parallel within weeks . 2) Eukaryotic expression systems facility for production of challenging protein targets. 3) A fully